We are monitoring the impact of COVID-19 on Neurotherapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1196
Share on
Share on

Global Neurotherapeutics Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Treatment, Disorders, Distribution Channels and Region – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1196
Pages: 182

Neurotherapeutics Market Size (2021 to 2026)

The size of the global neurotherapeutics market is estimated to grow at a healthy rate from 2021 to 2026.

Neurologic disorders are defined as a change in the function of a nervous system. These are mainly caused due to structural changes in the activity of the spinal cord, brain, and other nerves. These disorders are classified into three type’s namely Central nervous system disorders, Peripheral nervous system disorders, Autonomous nervous system disorders. These disorders involve progressive deterioration in mental and physical capabilities, disrupting the patient and the patient’s family. Genetic disorders, brain injury, infections, congenital health problems, and other traumas cause a change in brain activity, leading to various diseases such as Parkinson’s, neurological cancers, Alzheimer’s, Huntington’s disease, epilepsy, etc. So, Neurotherapeutics is used for the treatment of traumas causing diseases. Some of the neurotherapeutic products in the development phase include MEM 3454, NS2330, 189254, MKC-231, IL-13-PE38, 737004, SLV308, CEP 1347, KW-6002, MT 100, MT 300, Phosiphen, and BIBN4096 BS.

MARKET DRIVERS:

Y-O-Y growth in the incidences of neurological disorders and a growing aging population are expected to drive the global neurotherapeutics market.

Technological advancements are another significant factor favoring the market growth. For Instance, in June 2015, the U.S Food and Administration approved St. Jude Medical's Brio Neurostimulation System, a DBS system, to limit the symptoms of Parkinson's disease. The major factors driving the growth of the neurotherapeutics market are a rise in the geriatric population, increasing R&D expenditure, increasing Health care expenditures, a better understanding of the nature of neurologic diseases.  As an increasing number of the aged population are more susceptible to brain disorders. Therefore, the rise in the aging population and life expectancy of the people will increase the global neurotherapeutics market.

The introduction of novel and innovative devices is expected to support the global neurotherapeutics market growth during the forecast period. Growing R&D activities to figure out better neurotherapeutic treatment options are expected to fuel the market's growth rate. As per World Health Organization, in 2020, around 14.1% of the population would suffer from various neuro-related disorders, and neurological disorders contribute 6.3% of the global disease stress and causing death worldwide.

MARKET RESTRAINTS:

The factors challenging the market's growth are restrictions by regulatory bodies, lack of proper reimbursement policy, and lack of awareness in some developing countries.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Treatment, Disorders, Distribution Channels and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Abbott Laboratories, Inc., Becton Dickinson, And Company, Novartis AG, Pfizer, Inc., Johnson & Johnson, Biogen, Inc., GlaxoSmithKline, Inc., AstraZeneca Plc, Sanofi-Aventis, Spiegelberg, Stryker, Covidien, Medtronic, GE Healthcare and Merck & Co.

 

This research report on the global neurotherapeutics market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2026.

Neurotherapeutics Market - By Treatment:

  • Neurologic drugs
    • Oral administration
    • Injections
  • Neurologic devices
    • Electroconvulsive Therapy (ECT)
    • Vagus Nerve Stimulation (VNS)
    • Transcranial magnetic stimulation
    • Deep Brain Stimulator

Based on the treatment, the deep brain stimulator segment is expected to lead the global neurotherapeutics market. These devices send signals to various areas of the brain that are responsible for the body's moments. The rising incidences of neurological conditions like Alzheimer's and Parkinson's diseases are significant factors favoring the market.

Neurotherapeutics Market - By Disorders:

  • Central Nervous System (CNS) Disorders
  • Peripheral Nervous System (PNS) Disorders
  • Autonomous Nervous System (ANS) Disorders

Based on the disorders, the central nervous system disorders segment is the largest and most dominating segment. The growing awareness in people regarding CNS disorders, the availability of proper healthcare infrastructure, and favorable reimbursement policies are expected to support the growth.

The peripheral nervous system disorders segment is another lucrative segment and forecasted to account substantial share during the forecast period. The rising awareness in people regarding the various neurological conditions and the increasing government measures favor market growth. 

Neurotherapeutics Market - By Distribution channels:

  • Hospitals
  • Neurotherapeutic center
  • Clinical research organizations
  • Clinics

Based on the distribution channels, the segment of hospitals is expected to account for most of the market during the forecast period. The burgeoning number of deep brain stimulator surgeries implemented in the hospitals and technology advancements in devices with acceptable reimbursement policies are expected to accelerate the neurotherapeutics market growth during the forecast period.

Neurotherapeutics Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American region has the highest share in the market, followed by Europe and Asia-Pacific due to top market players' presence and major technological advancements. Asia-Pacific is an emerging market because many countries in this region are on the brink of strong economic growth (healthcare infrastructure, health facility up-gradation, and product expansion). These countries include Japan, China, India, Malaysia, and Australia.

KEY MARKET PARTICIPANTS:

Some of the notable companies operating in the global neurotherapeutics market profiled in the report are Abbott Laboratories, Inc., Becton Dickinson, And Company, Novartis AG, Pfizer, Inc., Johnson & Johnson, Biogen, Inc., GlaxoSmithKline, Inc., AstraZeneca Plc, Sanofi-Aventis, Spiegelberg, Stryker, Covidien, Medtronic, GE Healthcare and Merck & Co.

RECENT MARKET HAPPENINGS :

  • In September 2018, a San Francisco-based neurotherapeutics company, System1, announced the completion of 25 million USD in Series A Funding.
  • In February 2019, the China National Medical Products Association approved Biogen’s SPINRAZA to treat spinal muscular atrophy (SMA). This action of Biogen is expected to strengthen its presence in China.
  • In January 2020, Abbott announced its U.S. Food and Drug Administration approval for the new Deep Brain Stimulation system aiding the brain area called the internal globus pallidus (GPi). The GPI functions along with the DBS in developing the symptoms of Parkinson's disease and is not controlled by medication.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Neurologic Drugs 

                                                5.1.2.1 Oral Administration

                                                5.1.2.2 Injections

                                                5.1.2.3 Others

                                5.1.3 Neurologic Devices             

                                                5.1.3.1 Electroconvulsive Therapy (ECT)

                                                5.1.3.2 Vagus Nerve Stimulation (VNS)

                                                5.1.3.3 Transcranial magnetic stimulation

                                                5.1.3.4 Deep Brain Stimulator

                                                5.1.3.5 Others

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product               

                                5.1.6 Market Share Analysis, By Product                

                5.2 Disorders                    

                                5.2.1 Introduction           

                                5.2.2 Central Nervous system disorder  

                                5.2.3 Peripheral Nervous system disorder            

                                5.2.4 Autonomous Nervous system disorder       

                                5.2.5 Y-o-Y Growth Analysis, By Type      

                                5.2.6 Market Attractiveness Analysis, By Type     

                                5.2.7 Market Share Analysis, By Type      

                5.3 Distribution Channels                            

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Neurotherapeutic center  

                                5.3.4 Clinical Research organisations      

                                5.3.5 Clinics        

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7 Market Attractiveness Analysis, By Application        

                                5.3.8 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment

                                                6.1.3.3 By Disorders

                                                6.1.3.4 By Distribution Channels

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment

                                                6.1.4.3 By Disorders

                                                6.1.4.4 By Distributional Channels

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment

                                                6.1.5.3 By Disorders

                                                6.1.5.4 By Distribution channels

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 Australia  

                                6.3.6 South Korea           

                6.5 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America         

                6.6 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Abbott Laboratories               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Becton                         

                8.3 Novartis AG                

                8.4 Dickinson and Company                       

                8.5 Pfizer                            

                8.6 Johnson & Johnson                 

                8.7 Biogen                          

                8.8 Glaxosmithkline                       

                8.9 AstraZeneca               

                8.10 Sanofi Aventis                        

                8.11 Spiegelberg                             

                8.12 Covidien                    

                8.13 Medtronic                

                8.14 GE Health Care                       

                8.15 Merck & Co                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Neurotherapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  3. Global Neurologic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global Neurologic Devices Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  6. Global Central Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Peripheral Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global Autonomous Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  10. Global Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  11. Global Neurotherapeutic center Market, By Region, From 2021 to 2026 (USD Billion)
  12. Global Clinical research organisations Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global clinics Market, By Region, From 2021 to 2026 (USD Billion)
  14. Global Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  15. Global Oral Administrations Market, By Region, From 2021 to 2026 (USD Billion)
  16. Global Injections Market, By Region, From 2021 to 2026 (USD Billion)
  17. Global Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  18. Global Electroconvulsive Therapy (ECT) Market, By Region, From 2021 to 2026 (USD Billion)
  19. Global Vagus Nerve Stimulation (VNS) Market, By Region, From 2021 to 2026 (USD Billion)
  20. Global Transcranial magnetic stimulation Market, By Region, From 2021 to 2026 (USD Billion)
  21. Global Deep Brain Stimulator Market, By Region, From 2021 to 2026 (USD Billion)
  22. North America Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  23. North America Neurologic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  24. North America Neurologic Devices Market, By Region, From 2021 to 2026 (USD Billion)
  25. North America Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  26. North America Central Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  27. North America Peripheral Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  28. North America Autonomous Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  29. North America Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  30. North America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  31. North America Neurotherapeutic center Market, By Region, From 2021 to 2026 (USD Billion)
  32. North America Clinical research organisations Market, By Region, From 2021 to 2026 (USD Billion)
  33. North America clinics Market, By Region, From 2021 to 2026 (USD Billion)
  34. United States Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  35. United States Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  36. United States Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  37. Canada Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  38. Canada Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  39. Canada Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  40. North America Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  41. North America Oral Administrations Market, By Region, From 2021 to 2026 (USD Billion)
  42. North America Injections Market, By Region, From 2021 to 2026 (USD Billion)
  43. United States Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  44. Canada Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  45. North America Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  46. North America Electroconvulsive Therapy (ECT) Market, By Region, From 2021 to 2026 (USD Billion)
  47. North America Vagus Nerve Stimulation (VNS) Market, By Region, From 2021 to 2026 (USD Billion)
  48. North America Transcranial magnetic stimulation Market, By Region, From 2021 to 2026 (USD Billion)
  49. North America Deep Brain Stimulator Market, By Region, From 2021 to 2026 (USD Billion)
  50. United States Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  51. Canada Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  52. Europe Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  53. Europe Neurologic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  54. Europe Neurologic Devices Market, By Region, From 2021 to 2026 (USD Billion)
  55. Europe Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  56. Europe Central Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  57. Europe Peripheral Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  58. Europe Autonomous Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  59. Europe Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  60. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  61. Europe Neurotherapeutic center Market, By Region, From 2021 to 2026 (USD Billion)
  62. Europe Clinical research organisations Market, By Region, From 2021 to 2026 (USD Billion)
  63. Europe clinics Market, By Region, From 2021 to 2026 (USD Billion)
  64. U.K. Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  65. U.K. Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  66. U.K. Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  67. Germany Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  68. Germany Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  69. Germany Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  70. France Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  71. France Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  72. France Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  73. Italy Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  74. Italy Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  75. Italy Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  76. Spain Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  77. Spain Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  78. Spain Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  79. Europe Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  80. Europe Oral Administrations Market, By Region, From 2021 to 2026 (USD Billion)
  81. Europe Injections Market, By Region, From 2021 to 2026 (USD Billion)
  82. U.K. Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  83. Germany Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  84. France Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  85. Italy Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  86. Spain Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  87. Europe Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  88. Europe Electroconvulsive Therapy (ECT) Market, By Region, From 2021 to 2026 (USD Billion)
  89. Europe Vagus Nerve Stimulation (VNS) Market, By Region, From 2021 to 2026 (USD Billion)
  90. Europe Transcranial magnetic stimulation Market, By Region, From 2021 to 2026 (USD Billion)
  91. Europe Deep Brain Stimulator Market, By Region, From 2021 to 2026 (USD Billion)
  92. U.K. Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  93. Germany Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  94. France Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  95. Italy Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  96. Spain Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  97. Asia-Pacific Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  98. Asia-Pacific Neurologic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  99. Asia-Pacific Neurologic Devices Market, By Region, From 2021 to 2026 (USD Billion)
  100. Asia-Pacific Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  101. Asia-Pacific Central Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  102. Asia-Pacific Peripheral Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  103. Asia-Pacific Autonomous Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  104. Asia-Pacific Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  105. Asia-Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  106. Asia-Pacific Neurotherapeutic center Market, By Region, From 2021 to 2026 (USD Billion)
  107. Asia-Pacific Clinical research organisations Market, By Region, From 2021 to 2026 (USD Billion)
  108. Asia-Pacific clinics Market, By Region, From 2021 to 2026 (USD Billion)
  109. Japan Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  110. Japan Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  111. Japan Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  112. China Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  113. China Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  114. China Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  115. India Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  116. India Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  117. India Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  118. Asia-Pacific Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  119. Asia-Pacific Oral Administrations Market, By Region, From 2021 to 2026 (USD Billion)
  120. Asia-Pacific Injections Market, By Region, From 2021 to 2026 (USD Billion)
  121. Japan Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  122. China Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  123. India Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  124. Asia-Pacific Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  125. Asia-Pacific Electroconvulsive Therapy (ECT) Market, By Region, From 2021 to 2026 (USD Billion)
  126. Asia-Pacific Vagus Nerve Stimulation (VNS) Market, By Region, From 2021 to 2026 (USD Billion)
  127. Asia-Pacific Transcranial magnetic stimulation Market, By Region, From 2021 to 2026 (USD Billion)
  128. Asia-Pacific Deep Brain Stimulator Market, By Region, From 2021 to 2026 (USD Billion)
  129. Japan Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  130. China Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  131. India Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  132. Latin America Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  133. Latin America Neurologic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  134. Latin America Neurologic Devices Market, By Region, From 2021 to 2026 (USD Billion)
  135. Latin America Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  136. Latin America Central Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  137. Latin America Peripheral Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  138. Latin America Autonomous Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  139. Latin America Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  140. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  141. Latin America Neurotherapeutic center Market, By Region, From 2021 to 2026 (USD Billion)
  142. Latin America Clinical research organisations Market, By Region, From 2021 to 2026 (USD Billion)
  143. Latin America clinics Market, By Region, From 2021 to 2026 (USD Billion)
  144. Brazil Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  145. Brazil Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  146. Brazil Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  147. Rest of Latin America Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  148. Rest of Latin America Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  149. Rest of Latin America Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  150. Latin America Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  151. Latin America Oral Administrations Market, By Region, From 2021 to 2026 (USD Billion)
  152. Latin America Injections Market, By Region, From 2021 to 2026 (USD Billion)
  153. Brazil Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  154. Rest of Latin America Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  155. Latin America Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  156. Latin America Electroconvulsive Therapy (ECT) Market, By Region, From 2021 to 2026 (USD Billion)
  157. Latin America Vagus Nerve Stimulation (VNS) Market, By Region, From 2021 to 2026 (USD Billion)
  158. Latin America Transcranial magnetic stimulation Market, By Region, From 2021 to 2026 (USD Billion)
  159. Latin America Deep Brain Stimulator Market, By Region, From 2021 to 2026 (USD Billion)
  160. Brazil Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  161. Rest of Latin America Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  162. Middle East & Africa Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  163. Middle East & Africa Neurologic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  164. Middle East & Africa Neurologic Devices Market, By Region, From 2021 to 2026 (USD Billion)
  165. Middle East & Africa Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  166. Middle East & Africa Central Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  167. Middle East & Africa Peripheral Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  168. Middle East & Africa Autonomous Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  169. Middle East & Africa Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  170. Middle East & Africa Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  171. Middle East & Africa Neurotherapeutic center Market, By Region, From 2021 to 2026 (USD Billion)
  172. Middle East & Africa Clinical research organisations Market, By Region, From 2021 to 2026 (USD Billion)
  173. Middle East & Africa clinics Market, By Region, From 2021 to 2026 (USD Billion)
  174. Middle East Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  175. Middle East Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  176. Middle East Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  177. Africa Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  178. Africa Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  179. Africa Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  180. Middle East & Africa Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  181. Middle East & Africa Oral Administrations Market, By Region, From 2021 to 2026 (USD Billion)
  182. Middle East & Africa Injections Market, By Region, From 2021 to 2026 (USD Billion)
  183. Middle East Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  184. Africa Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  185. Middle East & Africa Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  186. Middle East & Africa Electroconvulsive Therapy (ECT) Market, By Region, From 2021 to 2026 (USD Billion)
  187. Middle East & Africa Vagus Nerve Stimulation (VNS) Market, By Region, From 2021 to 2026 (USD Billion)
  188. Middle East & Africa Transcranial magnetic stimulation Market, By Region, From 2021 to 2026 (USD Billion)
  189. Middle East & Africa Deep Brain Stimulator Market, By Region, From 2021 to 2026 (USD Billion)
  190. Middle East Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  191. Africa Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample